In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 89364-31-8, name is Tetrahydrofuran-3-carboxylic acid, introducing its new discovery. Recommanded Product: 89364-31-8
Compounds that may have anti-inflammatory activity are of general formula (I); wherein X1, is H or COR1, and X2 is H or COR2but X1, and X2are not both H; R1 and R2are the same or different and are each C1-4 alkyl substituted with R3, or a four to seven-membered ring which can be optionally substituted with R8and can contain one or more additional heteroatoms selected from O, S(O)nand NR9; is R3 is F, CF3, OR4, NR5R6O, S(O)n R7 ; R4, R5 and R6are the same or different and are each H or C1-4 alkyl optionally substituted with R3, or NR5R6 is a C4-6 heterocycloalkyl ring containing one or more heteroatoms selected from O, NR8 and S(O)n; each n is 0-2; R7 is C1-4 alkyl; R8 is as defined for R3 or C1-4 alkyl optionally substituted with R3or halogen; and R9 is H or C1-4 alkyl; or a salt, solvate or hydrate thereof.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 89364-31-8, and how the biochemistry of the body works.Recommanded Product: 89364-31-8
Reference：
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem